Dabur India (500096) Feb 2026 Filing Analysis

Management is continuing to drive consumption for Dabur Amla through a recently launched media campaign featuring Deepika Padukone. (+3 more commitments)

The HPC portfolio grew by 5%, with specific strength in Home Care (10%) and Skincare (9%). Toothpaste grew 7.3%, outperforming the category. (5 expanding across 1 engine)

International business is the primary growth engine, increasing its contribution to total sales and delivering high double-digit constant currency growth across almost all major markets. (5 expanding across 1 engine)

Dabur expanded its total reach to 8.4 million outlets, adding 0.5 million outlets in FY25, strengthening its rural and chemist network. (3 expanding, 2 stable)

The F&B segment has expanded its revenue share from 13% to 20% of the domestic business, driven by market leadership in Juices & Nectars (60.6% share). (4 expanding, 1 contracting)

Healthcare revenue share and growth declined significantly in Q4, primarily due to a delayed and shorter winter season impacting seasonal staples like Chyawanprash and Honey. (2 contracting, 1 stable across 1 engine)

New product variants and extensions are becoming significant contributors, particularly in the digestive category where they now exceed 15% of franchise sales. (2 accelerating across 2 signals, 1 leading indicator)

Hair oils are outperforming the broader category with significant market share gains, despite a general slowdown in the domestic FMCG business. (4 accelerating, 1 decelerating across 5 signals)

The toothpaste portfolio grew 7.3%, significantly outperforming the overall category growth of ~4%. Growth is driven by the 'Red' franchise and a massive 30% surge in the new Herbal toothpaste line. (4 accelerating, 1 steady across 5 signals)

New Product Development (NPD) is a consistent contributor to growth, accounting for 2.3% of total sales in FY25, with the highest contribution coming from the Home & Personal Care (HPC) vertical at 3.0%. (2 steady across 2 signals)

Dabur is expanding its 'Drinks' portfolio with new low-cost price points (Rs. 10 to Rs. 100) to drive mass-market penetration and seasonal resilience.

The risk is intensifying as consolidated material costs rose 4.3% in Q4 FY25, outpacing revenue growth of 0.6%. Operating profit margins compressed from 16.6% to 15.1% year-on-year. (5 intensifying, 1 high-severity)

Volume/Value growth dynamics are worsening in key domestic segments. Home & Personal Care declined 3.3% and Health Care declined 4.7% in value during Q4, suggesting both volume and pricing power are under pressure. (3 intensifying, 1 easing, 1 stable)

The risk is intensifying due to specific geopolitical events: 'Gen Z protests' in Nepal caused a 15% decline (INR 50-60 crore impact), and new US tariffs are affecting the Badshah spice exports. (3 intensifying, 2 easing)

The risk is intensifying as Oral Care value growth turned negative (-5.2%) in Q4. While management cites a 'high base effect,' the decline suggests competitive pressure is impacting top-line performance. (2 intensifying, 3 easing)

The risk is easing as the business returns to growth (1.5% to 2%) despite heavy monsoons and floods in Northern India. Management expects the upcoming harsh winter to drive demand for a third of their portfolio that is winter-centric. (1 easing, 4 stable, 1 high-severity)